altM: Funding, Investors & Team (Nov 2026)
altM's goal is to create and produce scalable biomaterials that can assist major industries in decreasing their carbon emissions throughout their supply chains. We utilize agricultural residues rich in lignocellulosic content as our primary source to manufacture advanced materials as sustainable alternatives to existing unsustainable options. Due to its eco-friendly attributes and practical characteristics, lignocellulosic residue can be utilized in the development of various materials, including paper, biofuels, polymers, and other useful chemicals.
altM has raised $13.8M across 2 funding rounds on record, the most recent a Series A of $10.3M announced in Nov 2026.
That round is above the $8.8M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
altM Company Profile and Key Stats
Latest funding round on record: Nov 2026.
altM Funding Rounds
altM raised $3.5M in a Seed announced in Sep 2023.
3.2 years later, a Series A of $10.3M was announced in Nov 2026.
altM Investors
14 investors are recorded in total; the 5 named above are those the record identifies.
altM Founders and Leadership Team
Contact details for the altM team: 2 of 2 have an email address on file, 2 have a LinkedIn profile.
Start 14-day free trial →altM Funding Compared to Other Biotechnology Startups
altM's latest round of $10.3M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like altM in Biotechnology and Bangalore
Companies Similar to altM
Venomics AI is a drug discovery platform using venom peptides for therapeutics.
Biodimension is offering biofabricated human tissues as an efficient animal alternative testing solutions to…
4baseCare offers advanced genomic solutions in precision oncology to assist individuals with cancer. The…
Pandorum Technologies Pvt. Ltd. is a Bangalore based biotechnology company with focus on tissue engineering…
PlasmaGen BioSciences is an Indian Bio-pharmaceutical organization specializing exclusively in Plasma Protein…
Cellarim is at the forefront of the biomanufacturing revolution. As a pioneer in the biotechnology business,…
ImmunitoAI is a life sciences (biotech) platform that leverages AI to revolutionize antibody discovery &…
Eyestem is a cell therapy company founded by a top-class management team consisting of clinical trial, cell…
QRL Bioscience is a science and technology-focused company dedicated to finding solutions for diabetic foot…
Ivory improves the aging process by promoting sharper thinking and better living. They assist in the early…
Prantae Solutions is a biotechnology company that develops cost-effective technologies for uncommon and…
ErlySign creates home-based early detection test kits for life-threatening illnesses such as Oral cancer,…
altM Funding FAQs
What does altM do?
altM's goal is to create and produce scalable biomaterials that can assist major industries in decreasing their carbon emissions throughout their supply chains. We utilize agricultural residues rich in lignocellulosic content as our primary source to manufacture advanced materials as sustainable alternatives to existing unsustainable options. Due to its eco-friendly attributes and practical characteristics, lignocellulosic residue can be utilized in the development of various materials, including paper, biofuels, polymers, and other useful chemicals.
How much funding has altM raised?
altM has raised $13.8M across 2 rounds on record. The most recent is a Series A of $10.3M announced in Nov 2026.
When did altM last raise funding?
altM's most recent funding round on record is a Series A of $10.3M, announced in Nov 2026.
Who has invested in altM?
Investors on record for altM include Rainmatter Capital, Omnivore, Mela Ventures, Theia Ventures, Aureolis Ventures. FundedIQ records 14 investors in total.
Who founded altM?
FundedIQ lists Yugal Jain (COO & Co-founder), Apoorv Garg (Founder) at altM.
Where is altM headquartered?
altM is based in Bangalore, Karnataka, India.
How many employees does altM have?
altM is in the 1-10 employee band.
When was altM founded?
altM was founded in 2022.
How does altM's funding compare to other Biotechnology startups?
altM's latest round of $10.3M is above the $8.8M median round size for Biotechnology companies on FundedIQ across 4,188 tracked companies over the last two years.
About FundedIQ's altM Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for altM is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.